H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents Corporation(CTSO)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-25 AccNo: 0001144204-18-022193 Size: 2 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-04-17,CFO,BLOCH KATHLEEN P. ,卖出,120普通股, $8.25
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-04-17,CFO,BLOCH KATHLEEN P. ,期权,120普通股, $4.69
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-02-21,CFO,BLOCH KATHLEEN P. ,卖出,10000普通股, $8.00
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-02-21,CFO,BLOCH KATHLEEN P. ,期权,10000普通股, $2.90
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-04-04 AccNo: 0001144204-18-019104 Size: 403 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-03-20 AccNo: 0001144204-18-015935 Size: 29 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-03-15,CFO,BLOCH KATHLEEN P. ,卖出,11176普通股, $8.25
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-03-15,CFO,BLOCH KATHLEEN P. ,期权,11176普通股, $4.69
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-03-13,CFO,BLOCH KATHLEEN P. ,卖出,1104普通股, $8.25